Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration (Q40178858)

18 September 2017

title

Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration (English)

1 reference

18 September 2017

0 references

Tatsuya Fujikawa

1

1 reference

18 September 2017

Hidenori Shiraha

2

1 reference

18 September 2017

Naoki Ueda

3

1 reference

18 September 2017

Nobuyuki Takaoka

4

1 reference

18 September 2017

Yutaka Nakanishi

5

1 reference

18 September 2017

Noriyuki Matsuo

6

1 reference

18 September 2017

Shigetomi Tanaka

7

1 reference

18 September 2017

Shin-ichi Nishina

8

1 reference

18 September 2017

Mayumi Suzuki

9

1 reference

18 September 2017

Akinobu Takaki

10

1 reference

18 September 2017

Kohsaku Sakaguchi

11

1 reference

18 September 2017

Yasushi Shiratori

12

1 reference

18 September 2017

language of work or name

English

0 references

publication date

25 January 2007

1 reference

Journal of Biological Chemistry

18 September 2017

published in

1 reference

18 September 2017

volume

282

1 reference

18 September 2017

issue

12

1 reference

18 September 2017

page(s)

8741-8748

1 reference

Management of hepatocellular cancer

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Clinical implications of circulating angiogenic factors in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Sema4D induces angiogenesis through Met recruitment by Plexin B1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

The semaphorin 4D receptor controls invasive growth by coupling with Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Tumor angiogenesis: past, present and the near future

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609358200

21 January 2018

Identifiers

DOI

10.1074/JBC.M609358200

1 reference

18 September 2017

1 reference